SOCRA CCRP Practice Exam 2025 – 400 Free Practice Questions to Pass the Exam

Question: 1 / 400

Which regulations dictate adverse event and serious adverse event reporting?

21 CFR 312.32 and 21 CFR 812.46

21 CFR 312.32 and 21 CFR 812.46 specifically address adverse event and serious adverse event reporting in clinical trials under the FDA. Option B (21 CFR 314.80 and 21 CFR 600.80) relates to post-marketing reporting for drug and biologic products, but does not cover clinical trials. Option C (21 CFR 210 and 21 CFR 211) refer to general good manufacturing practice regulations, not reporting requirements. Option D (ICH E6 and ICH E2A) are international guidelines, but do not have the same legal authority as FDA regulations. Therefore, these options are not as relevant to adverse event and serious adverse event reporting as option A.

Get further explanation with Examzify DeepDiveBeta

21 CFR 314.80 and 21 CFR 600.80

21 CFR 210 and 21 CFR 211

ICH E6 and ICH E2A

Next Question

Report this question

Download SOCRA CCRP Practice Exam PDF Study Guide
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy